Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity.

Stienstra R, Saudale F, Duval C, Keshtkar S, Groener JE, van Rooijen N, Staels B, Kersten S, Müller M.

Hepatology. 2010 Feb;51(2):511-22. doi: 10.1002/hep.23337.

PMID:
20054868
2.

Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor α expression by releasing cytokines.

Fang X, Zou S, Zhao Y, Cui R, Zhang W, Hu J, Dai J.

Arch Toxicol. 2012 Oct;86(10):1515-25. doi: 10.1007/s00204-012-0877-4. Epub 2012 May 31.

PMID:
22648072
3.

An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.

Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D.

Hepatology. 2011 Dec;54(6):2185-97. doi: 10.1002/hep.24599.

4.

Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.

Tanaka T, Masuzaki H, Ebihara K, Ogawa Y, Yasue S, Yukioka H, Chusho H, Miyanaga F, Miyazawa T, Fujimoto M, Kusakabe T, Kobayashi N, Hayashi T, Hosoda K, Nakao K.

Metabolism. 2005 Nov;54(11):1490-8.

PMID:
16253638
5.

Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.

Nagasawa T, Inada Y, Nakano S, Tamura T, Takahashi T, Maruyama K, Yamazaki Y, Kuroda J, Shibata N.

Eur J Pharmacol. 2006 Apr 24;536(1-2):182-91. Epub 2006 Feb 28.

PMID:
16574099
6.

Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.

Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC.

J Gastroenterol Hepatol. 2008 Feb;23(2):267-75. Epub 2007 Sep 12.

PMID:
17868330
7.

Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.

Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.

J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x.

PMID:
21929649
8.
9.

N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation.

Tapia G, Valenzuela R, Espinosa A, Romanque P, Dossi C, Gonzalez-Mañán D, Videla LA, D'Espessailles A.

Mol Nutr Food Res. 2014 Jun;58(6):1333-41. doi: 10.1002/mnfr.201300458. Epub 2014 Jan 16.

PMID:
24436018
11.
12.

Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways.

Goto T, Kim YI, Funakoshi K, Teraminami A, Uemura T, Hirai S, Lee JY, Makishima M, Nakata R, Inoue H, Senju H, Matsunaga M, Horio F, Takahashi N, Kawada T.

Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E1022-32. doi: 10.1152/ajpendo.00061.2011. Epub 2011 Aug 23.

13.

Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA, Seki E.

Gastroenterology. 2010 Jul;139(1):323-34.e7. doi: 10.1053/j.gastro.2010.03.052. Epub 2010 Mar 27.

14.

Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.

Zhang H, Shen WJ, Cortez Y, Kraemer FB, Azhar S.

Am J Physiol Gastrointest Liver Physiol. 2013 Jan 1;304(1):G72-86. doi: 10.1152/ajpgi.00328.2012. Epub 2012 Oct 25.

15.

Immunohistochemical distribution of activated nuclear factor kappaB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats.

Orfila C, Lepert JC, Alric L, Carrera G, Béraud M, Pipy B.

Histochem Cell Biol. 2005 Jun;123(6):585-93. Epub 2005 Jun 15.

PMID:
15959796
16.

IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis.

Negrin KA, Roth Flach RJ, DiStefano MT, Matevossian A, Friedline RH, Jung D, Kim JK, Czech MP.

PLoS One. 2014 Sep 12;9(9):e107265. doi: 10.1371/journal.pone.0107265. eCollection 2014.

17.

Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice.

Cui K, Yan G, Xu C, Chen Y, Wang J, Zhou R, Bai L, Lian Z, Wei H, Sun R, Tian Z.

J Hepatol. 2015 Jun;62(6):1311-8. doi: 10.1016/j.jhep.2014.12.027. Epub 2015 Jan 10.

PMID:
25582105
18.

Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.

François M, Richette P, Tsagris L, Fitting C, Lemay C, Benallaoua M, Tahiri K, Corvol MT.

Arthritis Rheum. 2006 Apr;54(4):1233-45.

19.

Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.

Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.

Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1.

20.

Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.

Jia Y, Qi C, Kashireddi P, Surapureddi S, Zhu YJ, Rao MS, Le Roith D, Chambon P, Gonzalez FJ, Reddy JK.

J Biol Chem. 2004 Jun 4;279(23):24427-34. Epub 2004 Mar 29.

Items per page

Supplemental Content

Write to the Help Desk